<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Cardiology Product Guide &#187; artery</title>
	<atom:link href="http://blog.cardiologyproductguide.com/tag/artery/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.cardiologyproductguide.com</link>
	<description>A comprehensive guide to cardiology products for medical professionals </description>
	<lastBuildDate>Tue, 14 Jun 2011 11:39:11 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>Medtronic Integrity Coronary Stent Gets FDA Approval</title>
		<link>http://blog.cardiologyproductguide.com/2010/09/23/medtronic-integrity-coronary-stent-gets-fda-approval/</link>
		<comments>http://blog.cardiologyproductguide.com/2010/09/23/medtronic-integrity-coronary-stent-gets-fda-approval/#comments</comments>
		<pubDate>Thu, 23 Sep 2010 06:35:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Devices]]></category>
		<category><![CDATA[Stents]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[artery]]></category>
		<category><![CDATA[continuous sinusoid technology]]></category>
		<category><![CDATA[Coronary Stent System]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Medronic]]></category>
		<category><![CDATA[stent]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/?p=416</guid>
		<description><![CDATA[The FDA has approved Medronic&#8217;s Integrity Coronary Stent System, based on an advanced biomedical engineering called continuous sinusoid technology, enabling the exploration of other new device concepts, such as a polymer-free drug-filled stent. The stent is said to feature a new, more flexible construction which is easier for surgeons to insert. A stent is a [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.cardiologyproductguide.com/files/2010/09/Medtronic2.png"><img class="alignright size-full wp-image-417" style="margin: 5px" src="http://blog.cardiologyproductguide.com/files/2010/09/Medtronic2.png" border="0" alt="Medtronic" width="200" height="53" /></a>The FDA has approved Medronic&#8217;s Integrity Coronary Stent System, based on an advanced biomedical engineering called continuous sinusoid technology, enabling the exploration of other new device concepts, such as a polymer-free drug-filled stent. The stent is said to feature a new, more flexible construction which is easier for surgeons to insert. A stent is a metal mesh which is placed inside an artery after it has been cleared of blockage.</p>
<p>Read the full story <a href="http://www.medicalnewstoday.com/articles/201809.php" target="_blank">here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2010/09/23/medtronic-integrity-coronary-stent-gets-fda-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study: Statins lower death risk after artery surgery</title>
		<link>http://blog.cardiologyproductguide.com/2009/09/08/study-statins-lower-death-risk-after-artery-surgery/</link>
		<comments>http://blog.cardiologyproductguide.com/2009/09/08/study-statins-lower-death-risk-after-artery-surgery/#comments</comments>
		<pubDate>Tue, 08 Sep 2009 16:11:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Surgery]]></category>
		<category><![CDATA[artery]]></category>
		<category><![CDATA[artery sugery]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[heart attack]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[Lescol]]></category>
		<category><![CDATA[pulmonary artery]]></category>
		<category><![CDATA[statin]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/?p=146</guid>
		<description><![CDATA[A Dutch study showed that people who took preventive doses of the statin pills, such as Lescol, before and after their operations to get an artery unclogged or repaired were much less likely to die or have a heart attack afterward. Statins are widely prescribed to reduce cholesterol and prevent heart disease.]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.cardiologyproductguide.com/files/2009/09/Lescol.png"><img class="alignright size-full wp-image-147" style="margin: 5px" src="http://blog.cardiologyproductguide.com/files/2009/09/Lescol.png" alt="Lescol" width="200" height="64" /></a>A Dutch study showed that people who took preventive doses of the statin pills, such as Lescol, before and after their operations to get an artery unclogged or repaired were much less likely to die or have a heart attack afterward. Statins are widely prescribed to reduce cholesterol and prevent heart disease.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2009/09/08/study-statins-lower-death-risk-after-artery-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves Effient for thrombotic cardiovascular</title>
		<link>http://blog.cardiologyproductguide.com/2009/07/13/fda-approves-effient-for-thrombotic-cardiovascular/</link>
		<comments>http://blog.cardiologyproductguide.com/2009/07/13/fda-approves-effient-for-thrombotic-cardiovascular/#comments</comments>
		<pubDate>Tue, 14 Jul 2009 04:40:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diagnostics & Theraputics]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Stents]]></category>
		<category><![CDATA[acutecoronary syndromes]]></category>
		<category><![CDATA[artery]]></category>
		<category><![CDATA[Daiichi Sankyo]]></category>
		<category><![CDATA[Effient]]></category>
		<category><![CDATA[Eli Lilly]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[percutaneous coronary intervention]]></category>
		<category><![CDATA[stent]]></category>
		<category><![CDATA[stent thrombosis]]></category>
		<category><![CDATA[thrombotic cardiovascular events]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/2009/07/13/fda-approves-effient-for-thrombotic-cardiovascular/</guid>
		<description><![CDATA[Daiichi Sankyo Inc and Eli Lilly received approval from the US Food and Drug Administration (FDA) for Effient (prasugrel) tablets to be used for the reduction of thrombotic cardiovascular events. Effient reduces thrombotic cardiovascular events (including stent thrombosis) in patients suffering from acutecoronary syndromes and undergoing an artery-opening procedure known as percutaneous coronary intervention (PCI). [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://blog.cardiologyproductguide.com/files/2009/07/effient.png" align="right" height="84" width="200" vspace="5" hspace="5" />Daiichi Sankyo Inc and Eli Lilly received approval from the US Food and Drug Administration (FDA) for Effient (prasugrel) tablets to be used for the reduction of thrombotic cardiovascular events. Effient reduces thrombotic cardiovascular events (including stent thrombosis) in patients suffering from acutecoronary syndromes and undergoing an artery-opening procedure known as percutaneous coronary intervention (PCI). PCI usually includes the placement of a stent to help keep the artery open.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2009/07/13/fda-approves-effient-for-thrombotic-cardiovascular/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

